Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in nonalcoholic fatty liver disease
Taekyeong Yoo, Sae Kyung Joo, Hyo Jung Kim, Ho Kim, Hyungtai Sim, Ji-Eun Lee, Hee‐Hoon Kim, Sunhee Jung, Youngha Lee, Oveis Jamialahmadi, Stefano Romeo, Won‐Il Jeong, Geum‐Sook Hwang, Keon Wook Kang, Jae Woo Kim, , Murim Choi
The paper identifies AGXT2 as a gene with an anti-fibrotic effect in NAFLD through eQTL screening and functional validation.
Journal of Hepatology · Apr 20, 2021Peer-reviewedGenetics